Related Experiment Video
Updated: May 16, 2026

Assessment of Cardiac Function and Myocardial Morphology Using Small Animal Look-locker Inversion Recovery (SALLI) MRI in Rats
Published on: July 19, 2013
[MRI in cardiac sarcoidosis and amyloidosis]
1Institut für Klinische Radiologie, Klinikum der Ludwig-Maximilians-Universität München, Campus Grosshadern, Deutschland. kerstin.bauner@med.uni-muenchen.de
Insights
Diagnosing cardiac sarcoidosis and amyloidosis is vital for patient outcomes. Cardiac MRI, including late gadolinium enhancement, is recommended for accurate diagnosis when infiltrative cardiomyopathy is suspected.
Area of Science:
- Cardiology
- Radiology
- Infiltrative Cardiomyopathy
Context:
- Sarcoidosis and amyloidosis are multisystem disorders that can affect the heart.
- Isolated cardiac involvement is rare but critical for prognosis.
- Early diagnosis of cardiac sarcoidosis and amyloidosis is essential for timely treatment.
Purpose:
- To evaluate the role of cardiac magnetic resonance imaging (MRI) in diagnosing cardiac sarcoidosis and amyloidosis.
- To compare the diagnostic performance of MRI techniques, including T1 mapping and late gadolinium enhancement (LGE).
Summary:
- Echocardiography is an initial imaging tool, but cardiac MRI with LGE significantly improves sensitivity and specificity for detecting cardiac sarcoidosis and amyloidosis.
- T1 mapping is an emerging technique for quantifying myocardial enhancement in cardiac amyloidosis.
- LGE in cardiac sarcoidosis correlates with patient outcomes, while T1-mapping in amyloidosis may offer prognostic value.
Impact:
- Cardiac MRI, particularly with LGE, is crucial for establishing the diagnosis of cardiac sarcoidosis and amyloidosis.
- Improved diagnostic accuracy leads to better patient management and prognosis.
- This study highlights the utility of advanced MRI techniques in managing rare but serious cardiac conditions.
Clinical/Methodical Issue:
Sarcoidosis and amyloidosis are both multisystem disorders, which may involve the heart; however, isolated cardiac disease is rare. Diagnosis of cardiac sarcoidosis and amyloidosis is crucial because the patient prognosis is dependent on cardiac involvement and early treatment.
Standard Radiological Methods:
Echocardiography is the first line imaging modality in the diagnostic work-up of both diseases, possibly giving hints towards the correct diagnosis. Besides myocardial biopsy and radionuclide studies cardiac magnetic resonance imaging (MRI) is routinely performed in patients suspect of having infiltrative cardiomyopathy.
Methodical Innovations:
The T1 mapping procedure is currently being evaluated as a new technique for detection and quantification of global myocardial enhancement, as seen in cardiac amyloidosis.
Performance:
Sensitivities and specificities for detection of cardiac sarcoidosis and amyloidosis can be significantly improved by MRI, especially with late gadolinium enhancement (LGE) imaging. In cardiac sarcoidosis the use of LGE is outcome-related while in amyloidosis analysis of T1-mapping may be of prognostic value.
Practical Recommendations:
If cardiac involvement in sarcoidosis or amyloidosis is suspected cardiac MRI including LGE should be performed for establishing the diagnosis.
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Imaging Studies for Cardiovascular System V: CT
Myocarditis II: Clinical Features and Diagnostic Tests
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
